Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM
Principal Scientist
Watson Pharmaceuticals - Fort Lauderdale, FL
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US
Clinical Trials Site Director
Lovelace Respiratory Research Institute - Albuquerque, NM
Laboratory Facility Manager
International AIDS Vaccine Initiative - New York, NY

More Jobs >>

Events

New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami
Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia

More Events >>

Related Tags >> breast cancer ovarian cancer vaccine therapeutic vaccines NeuVax

RXi Pharmaceuticals News

Most Popular RXi Pharmaceuticals Story

NeuVax - 10 promising therapeutic vaccines

October 27, 2011 — 6:59am ET

Vaccine: NeuVaxCompany: RXi PharmaceuticalsTarget: Breast cancer In September, RXi Pharmaceuticals received FDA permission to go ahead with a Phase III clinical trial of an experimental therapeutic Read more...

RXi Pharmaceuticals Press Releases

RXi Pharmaceuticals(R) to Strengthen Strategic Focus by Separating Into Two Publicly Traded Companies
RXi Pharmaceuticals Licenses Novel, Targeted Cancer Vaccine for Gynecological Cancers
RXi Pharmaceuticals Provides Positive NeuVax(TM) Phase 3 Clinical Trial Update
RXi Pharmaceuticals Strengthens NeuVax™ (E75) Patent Portfolio
RXi Pharmaceuticals to Present at BIO International Convention

Latest Headlines

NeuVax - 10 promising therapeutic vaccines
October 27, 2011
RXi licences ovarian cancer vax
September 21, 2011
FDA lifts clinical hold on RXi's breast cancer vaccine
September 15, 2011

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK